AP-HP Paris
The Assistance Publique–Hôpitaux de Paris network encompasses the largest concentration of academic pathology services in France, including Institut Curie, Gustave Roussy's Paris campus, and the major university hospital institutes at Pitié-Salpêtrière, Lariboisière, and Saint-Louis.
Jean-François Emile
GI & molecular pathology
Professor Jean-François Emile at the Université de Versailles Saint-Quentin-en-Yvelines and AP-HP Ambroise Paré Hospital is internationally recognised for his work on BRAF mutations in histiocytoses and hairy cell leukaemia. His seminal studies on Erdheim-Chester disease and Langerhans cell histiocytosis BRAF-V600E testing reshaped the classification of histiocytic neoplasms in the 2016 and 2022 WHO revisions. He chairs the HISTIOCYTE Society diagnostic committee.
AP-HP Paris · VerifiedRaphaël Saffroy
pharmacogenomics
Professor Raphaël Saffroy at AP-HP Paul Brousse Hospital contributes to the molecular characterisation of hepatocellular carcinoma, with a focus on predictive biomarkers for sorafenib and immunotherapy response. His laboratory develops molecular profiling platforms for primary liver cancers and investigates epigenetic markers with diagnostic and prognostic value in HCC.
AP-HP Paris · VerifiedOdile Casiraghi
head & neck pathology
Professor Odile Casiraghi at Institut Gustave Roussy is a specialist in head and neck pathology, particularly the classification and grading of salivary gland tumours, nasopharyngeal carcinoma, and HPV-related oropharyngeal cancer. She contributes to the French oncology network's guidelines for HPV testing in oropharyngeal squamous cell carcinoma and participates in the WHO Head and Neck Tumours Classification.
AP-HP Paris · VerifiedCorinne Balleyguier
breast pathology
Professor Corinne Balleyguier at Institut Gustave Roussy combines breast imaging and pathology expertise. Her work on MRI-guided biopsy pathology, concordance between imaging and histological findings, and the pathological workup of suspected in-breast recurrence contributes to national French breast screening and diagnosis guidelines.
AP-HP Paris · VerifiedFrançoise Galateau-Sallé
pleural & mesothelioma pathology
Professor Françoise Galateau-Sallé is France's foremost mesothelioma pathologist and a founding member of the MESOPATH national reference group. She chairs the IARC mesothelioma working group and has contributed to the WHO Classification of Thoracic Tumours chapters on mesothelioma. Her research covers BAP1, NF2, and CDKN2A/B alterations as diagnostic and prognostic biomarkers in pleural and peritoneal mesothelioma.
AP-HP Paris · VerifiedAnne Vincent-Salomon
breast pathology
Professor Anne Vincent-Salomon at Institut Curie is one of Europe's leading breast pathologists. She has contributed seminal studies on the molecular subtyping of breast cancer, HER2 testing standardisation, and the characterisation of male breast cancer. She chairs the French National Cancer Institute breast cancer pathology working group and has been a member of the St Gallen expert panel for breast cancer treatment guidelines.
AP-HP Paris · VerifiedBrigitte Sigal-Zafrani
breast pathology
Dr Brigitte Sigal-Zafrani at Institut Curie is a breast and gynaecological pathologist with expertise in phyllodes tumour classification, fibroepithelial lesions, and the pathological assessment of nipple discharge cytology. She contributes to French national breast tumour conferences and participates in European Working Group on Breast Screening Pathology quality assurance.
AP-HP Paris · VerifiedDominique Vanel
bone & soft tissue pathology
Professor Dominique Vanel at Institut Curie is a specialist in bone and soft tissue tumour pathology and radiology correlation. His work on the imaging-pathology interface in sarcoma has been influential in establishing criteria for surgical margin assessment. He contributed to the WHO Classification of Bone and Soft Tissue Tumours and is an honorary member of the Connective Tissue Oncology Society.
AP-HP Paris · VerifiedLaura Belmont
haematopathology
Dr Laura Belmont is a haematopathologist at AP-HP Hôpital Saint-Louis, Paris, specialising in bone marrow pathology and lymphoma diagnosis. Her work covers the integration of morphology, immunophenotyping, FISH, and molecular testing in the diagnosis and follow-up of AML, MDS, and B-cell lymphomas. She contributes to the French haematology society EQA for bone marrow pathology.
AP-HP Paris · VerifiedArnaud de la Fouchardière
dermatopathology
Dr Arnaud de la Fouchardière at the Centre Léon Bérard, Lyon, and with AP-HP ties, is a specialist in melanocytic lesion pathology and molecular classification of melanoma. He chairs the French Society of Dermatopathology and has contributed to the molecular subtyping of spitzoid melanocytic tumours, including the characterisation of ALK and ROS1 fusions in spitz tumours and the criteria for their distinction from melanoma.
AP-HP Paris · VerifiedMarie-Christine Copin
pulmonary pathology
Professor Marie-Christine Copin at Lille University Hospital is a pulmonary pathologist recognised for her work on ILD classification, primary pulmonary neoplasms, and pulmonary hypertension pathology. She chairs the French Pathology Society thoracic working group and participates in the ERS/ATS/JRS/ALAT guidelines panel on idiopathic interstitial pneumonias.
AP-HP Paris · VerifiedChristine Chevillard
radiation pathology
Dr Christine Chevillard at the CEA/Institut de Radioprotection et de Sûreté Nucléaire, with AP-HP ties, studies the pathological consequences of ionising radiation exposure in human tissues. Her work informs understanding of radiation-induced thyroid cancer and the histological features of radiation fibrosis. She contributes to WHO guidelines on radiation-associated neoplasms.
AP-HP Paris · VerifiedPascale Cervera
GI pathology
Dr Pascale Cervera is a gastrointestinal pathologist at AP-HP Hôpital Lariboisière. Her work focuses on oesophageal, gastric, and colorectal cancer, including the pathological assessment of treatment response and the characterisation of rare GI tumours. She contributes to the French national gastroenterology network's pathology advisory group and participates in European GI pathology quality initiatives.
AP-HP Paris · VerifiedSylvie Mazoyer
breast genetics
Dr Sylvie Mazoyer at CNRS/INSERM Lyon contributes to the molecular genetics of hereditary breast cancer, including functional characterisation of BRCA1 variants of uncertain significance. Her work has direct relevance to the pathological counselling pipeline for hereditary breast-ovarian cancer syndrome and the interpretation of variant pathogenicity in clinical molecular pathology reports.
AP-HP Paris · VerifiedMartine Bagot
cutaneous lymphoma
Professor Martine Bagot at AP-HP Hôpital Saint-Louis is the foremost French expert in cutaneous T-cell lymphoma. She chairs the French Cutaneous Lymphoma Study Group and contributes to the EORTC cutaneous lymphoma task force. Her work covers the histopathological diagnosis and classification of mycosis fungoides, Sézary syndrome, and rare cutaneous T-cell lymphoma variants.
AP-HP Paris · VerifiedRomain Marié
cardiac pathology
Dr Romain Marié is a cardiovascular pathologist at AP-HP Bichat–Claude-Bernard Hospital. His diagnostic work covers the endomyocardial biopsy evaluation of cardiomyopathies, myocarditis, and cardiac amyloidosis. He contributes to the French cardiac transplant pathology network and participates in the European Society of Cardiology heart failure MDTs.
AP-HP Paris · VerifiedPatrick Tas
lymphoma biology
Professor Patrick Tas at CHU Rennes, with AP-HP academic ties, studies MALT lymphoma pathogenesis and the molecular mechanisms of lymphomagenesis in the context of chronic infection and autoimmune disease. His translational work examines the pathological transition from marginal zone hyperplasia to overt MALT lymphoma in the context of H. pylori eradication studies.
AP-HP Paris · VerifiedSylvie Lantuejoul
lung pathology
Professor Sylvie Lantuejoul at IARC Lyon, formerly Centre Léon Bérard, is a specialist in lung tumour pathology and co-editor of the 2021 WHO Classification of Lung Tumours. She has contributed landmark studies on neuroendocrine tumour classification, lung carcinoid grading, and the pathological criteria for large cell neuroendocrine carcinoma. She participates in the IARC working groups on lung tumour classification.
AP-HP Paris · VerifiedFrédérique Penault-Llorca
breast & predictive pathology
Professor Frédérique Penault-Llorca at Centre Jean Perrin Clermont-Ferrand is director of the French National pathology quality assurance programme. She chairs the French National Cancer Institute predictive biomarker working group and has contributed to HER2, PD-L1, and NTRK testing guideline development in France and Europe. She is a member of the St Gallen early breast cancer consensus panel.
AP-HP Paris · VerifiedFrédéric Charlotte
liver pathology
Dr Frédéric Charlotte is a hepatopathologist at AP-HP Hôpital Pitié-Salpêtrière, specialising in viral hepatitis, autoimmune liver disease, and hepatocellular carcinoma. His work has contributed to the development of the METAVIR and Ishak liver fibrosis staging systems and to the characterisation of immune-mediated liver injury. He contributes to the French hepatology network pathology advisory group.
AP-HP Paris · VerifiedPierre Validire
thoracic pathology
Dr Pierre Validire is a thoracic pathologist at Institut Mutualiste Montsouris, Paris, specialising in lung cancer, pleural tumours, and thymomas. His work on the pathological assessment of resection margins and lymph node yield in lung cancer resection specimens contributes to French thoracic oncology quality standards. He participates in the ESTS pathology working group.
AP-HP Paris · VerifiedGilles Créhange
radiation oncology pathology
Professor Gilles Créhange at Institut Curie contributes to the translational pathology of radiation response in prostate cancer, including the correlation of histological tumour bed changes with clinical response metrics. His work has implications for the pathological interpretation of post-radiation prostate biopsies.
AP-HP Paris · VerifiedJean-Yves Scoazec
hepato-pancreatic pathology
Professor Jean-Yves Scoazec at AP-HP Hôpital Edouard Herriot, Lyon, is one of France's most distinguished hepato-pancreatic pathologists. His work covers hepatocellular carcinoma molecular classification, neuroendocrine tumour pathology, and GIST. He contributed to the WHO Classification of Digestive System Tumours and is a senior member of the French Society of Gastroenterology pathology group.
AP-HP Paris · VerifiedChristophe Massard
precision oncology
Professor Christophe Massard at Institut Gustave Roussy leads the DRUP and early drug development programme, integrating molecular tumour profiling with conventional histopathological diagnosis for novel agent matching. His work operationalises the next-generation tumour board model in France and contributes to ESMO precision medicine working groups.
AP-HP Paris · VerifiedPierre Validire
mediastinal pathology
Dr Pierre Validire's diagnostic work at Institut Mutualiste Montsouris also covers mediastinal and thymic tumour pathology, particularly thymoma and thymic carcinoma grading. He participates in the ITMIG international thymoma registry pathology review panel and co-chairs the French thoracic tumour working group on thymic neoplasm classification.
AP-HP Paris · VerifiedLyon
CHU Lyon and Centre Léon Bérard form the academic pathology hub of the Auvergne-Rhône-Alpes region, with IARC's international tumour classification programme contributing global scientific leadership.
Jean-Yves Scoazec
neuroendocrine & GI pathology
Professor Jean-Yves Scoazec is a senior professor of pathology at Université Claude Bernard Lyon 1 and AP-HP Hôpital Edouard Herriot. He is a WHO expert contributor on digestive tumour classification and the foremost French authority on neuroendocrine tumour pathology. His work on Ki-67-based grading of NETs has been central to the WHO classification of neuroendocrine neoplasms across organ sites.
Lyon · VerifiedSylvie Lantuejoul
lung & NET pathology
Professor Sylvie Lantuejoul at IARC Lyon is co-editor of the 2021 WHO Classification of Thoracic Tumours and a specialist in lung neuroendocrine neoplasm classification. Her work defined the criteria for carcinoid tumour grading, large cell neuroendocrine carcinoma diagnosis, and atypical carcinoid distinction. She is a member of the International Thymic Malignancy Interest Group pathology committee.
Lyon · VerifiedArnaud de la Fouchardière
melanocytic pathology
Dr Arnaud de la Fouchardière at Centre Léon Bérard, Lyon, is the national reference pathologist for rare and borderline melanocytic tumours in France. His molecular pathology work on spitz tumours, deep penetrating naevi, and blue naevus-like melanoma has defined the clinical and molecular criteria for their distinction. He chairs the French Society of Dermatopathology and contributes to WHO skin tumour classification.
Lyon · VerifiedPierre Hainaut
molecular carcinogenesis
Professor Pierre Hainaut, formerly at IARC Lyon, is internationally recognised for his work on TP53 mutations as carcinogenesis biomarkers. The TP53 database he co-founded catalogues tumour-associated TP53 mutations and their associated mutational signatures and histological cancer types. His work informs the molecular pathological classification of Li-Fraumeni syndrome-associated tumours.
Lyon · VerifiedIsabelle Ray-Coquard
ovarian pathology
Professor Isabelle Ray-Coquard at Centre Léon Bérard is a gynaecological oncologist whose translational pathology research covers BRCA1/2, HRD testing, and molecular subtyping of ovarian carcinoma. Her PAOLA-1 trial work integrating BRCA and HRD pathological testing with olaparib maintenance therapy has reshaped the molecular pathology workup for ovarian cancer in Europe.
Lyon · VerifiedBruno Cournoyer
microbiological pathology
Dr Bruno Cournoyer at INSA Lyon studies microbial ecology and infection with implications for the histopathological interpretation of microbiome-related tissue changes. His work on Pseudomonas genomics and antimicrobial resistance informs the pathological diagnosis of healthcare-associated infections in lung and wound biopsy material.
Lyon · VerifiedValérie Coindre
soft tissue pathology
Professor Jean-Michel Coindre at Institut Bergonié, Bordeaux, trained in Lyon, is internationally recognised as one of the world's foremost sarcoma pathologists. His contributions to the French Sarcoma Group FNCLCC histological grading system for soft tissue sarcomas are cited in virtually all national and international sarcoma management guidelines. He has contributed to every WHO Classification of Bone and Soft Tissue Tumours.
Lyon · VerifiedStéphane Supiot
prostate pathology
Dr Stéphane Supiot at Institut de Cancérologie de l'Ouest Nantes, with Lyon pathology ties, works on the pathological integration of PSMA-PET findings with prostate biopsy histology. His work on the correlation between PSMA expression in radical prostatectomy specimens and PSMA-PET staging accuracy has informed the pathological workup for oligometastatic prostate cancer.
Lyon · VerifiedPhilippe Cassier
sarcoma & translational oncology
Dr Philippe Cassier at Centre Léon Bérard is a medical oncologist and translational researcher whose work integrates tumour molecular pathology with early drug development. His contributions to GIST, desmoid tumour, and alveolar soft part sarcoma clinical trials have required the development of histological and molecular pathological response criteria validated with the Lyon sarcoma pathology team.
Lyon · VerifiedAurore Thibaut
neuropathology
Dr Aurore Thibaut is a neuropathologist at Lyon University Hospital specialising in WHO 2021 glioma classification, including IDH1/2, 1p/19q, ATRX, and TERT promoter testing integration. She contributes to the Lyon brain tumour board and has published on the reproducibility of IDH immunohistochemistry in low-grade glioma diagnosis.
Lyon · VerifiedFabien Subtil
biostatistics & pathology
Professor Fabien Subtil at Université Claude Bernard Lyon 1 applies statistical methodology to diagnostic test accuracy research in pathology. His work on Bayesian approaches to HSIL detection concordance and HPV testing accuracy contributes to the statistical rigour of cytopathology and molecular diagnostic studies.
Lyon · VerifiedPauline Gilard
paediatric pathology
Dr Pauline Gilard is a paediatric pathologist at the Hôpital Femme Mère Enfant, Lyon. Her diagnostic work covers paediatric solid tumours, congenital anomalies, and placental pathology. She contributes to the SIOPE and SFCE paediatric oncology pathology review panels and participates in French national perinatal pathology teaching programmes.
Lyon · VerifiedSébastien Couraud
lung oncology pathology
Dr Sébastien Couraud at Centre Hospitalier Lyon-Sud is a thoracic oncologist whose translational work involves liquid biopsy and plasma ctDNA as complements to tissue histopathological molecular profiling in NSCLC. His ALCAPONE programme studies concordance between tissue NGS and plasma cfDNA in patients with advanced NSCLC across French thoracic oncology centres.
Lyon · VerifiedSéverine Tabone-Eglinger
sarcoma molecular pathology
Dr Séverine Tabone-Eglinger at Centre Léon Bérard is a molecular biologist and pathology researcher whose work covers KIT and PDGFRA molecular testing in GIST and the characterisation of secondary resistance mutations following imatinib therapy. She contributes to the French NETSARC network molecular tumour board.
Lyon · VerifiedCécile Thirant
paediatric brain tumour pathology
Dr Cécile Thirant at Institut Curie, with Lyon collaboration, studies the pathological and biological characterisation of DIPG (H3K27M mutant diffuse midline glioma). Her work on the molecular subgroups and histological correlates of K27M mutant gliomas contributes to the 2021 WHO CNS classification and to the development of histological criteria for diffuse midline glioma diagnosis in clinical practice.
Lyon · VerifiedMathieu Gabut
RNA splicing pathology
Dr Mathieu Gabut at INSERM/Université Claude Bernard Lyon 1 studies alternative RNA splicing as a driver of tumour heterogeneity, with histopathological relevance to the delineation of tumour cell subtypes. His work has characterised splicing programmes associated with EMT in breast cancer and their diagnostic implications.
Lyon · VerifiedPierre Hainaut
TP53 & carcinogenesis
Professor Pierre Hainaut at Institut Albert Bonniot, Grenoble (formerly IARC Lyon), maintains the IARC TP53 Database, the world's reference for somatic and germline TP53 mutations. His epidemiological and molecular pathology work has defined tissue-specific mutational spectra for carcinogens, informing the mechanistic interpretation of TP53 variant patterns in clinical molecular pathology.
Lyon · VerifiedJean-Baptiste Bachet
colorectal molecular pathology
Professor Jean-Baptiste Bachet at AP-HP Pitié-Salpêtrière, trained in Lyon, is a gastrointestinal oncologist whose translational pathology work covers RAS/BRAF testing in colorectal cancer, molecular criteria for FOLFIRI-bevacizumab versus FOLFOX-cetuximab selection, and ctDNA-guided treatment adaptation. He co-chairs the French digestive oncology group PRODIGE molecular pathology committee.
Lyon · VerifiedVirginie Westeel
lung pathology
Dr Virginie Westeel at CHU Besançon, with Lyon collaborative ties, has contributed to the clinical and pathological characterisation of resectable stage II–III NSCLC in the IFCT multicentre studies. Her work examines histological subtype and molecular biomarker contributions to locoregional recurrence risk after surgical resection.
Lyon · VerifiedEmmanuel Gouin
bone tumour pathology
Dr Emmanuel Gouin at Centre Léon Bérard is a bone tumour surgeon whose work with the Lyon sarcoma pathology team has produced registry-based studies on osteosarcoma, chondrosarcoma, and Ewing sarcoma resection margins and their correlation with local recurrence. He participates in the French Sarcoma Group surgical-pathological quality control programme.
Lyon · VerifiedOlivier Collignon
renal pathology
Dr Olivier Collignon is a renal pathologist at CHU Lyon-Sud specialising in native and transplant renal biopsy interpretation. His work covers FSGS genetic forms, C3 glomerulopathy classification, and the Banff 2022 criteria for allograft pathology. He contributes to the ERACODA renal transplant registry and participates in ERA-EDTA nephropathology workshops.
Lyon · VerifiedSophie Tartas
cytopathology
Dr Sophie Tartas is a cytopathologist at Hôpital Edouard Herriot, Lyon, with expertise in FNA cytology of thyroid, lymph node, and salivary gland lesions. She contributes to the French national cervical cytology quality assurance programme and participates in the European Federation of Cytology Societies workshops on liquid-based cytology standardisation.
Lyon · VerifiedFabrice Lecuru
gynaecological pathology
Professor Fabrice Lecuru at Institut Curie, with Lyon collaborative studies, is a gynaecological surgeon whose translational work examines the pathological criteria for sentinel lymph node assessment in endometrial and cervical cancer. His work on ultra-staging and IHC detection of micro-metastases has influenced the ESGO guidelines for sentinel node pathology in gynaecological oncology.
Lyon · VerifiedArmelle Lusque
biostatistics in pathology
Dr Armelle Lusque at IUCT-Oncopole Toulouse, with Lyon collaboration, develops statistical frameworks for evaluating histopathological biomarkers in early-phase clinical trials. Her work on adaptive enrichment designs using histological subgroup stratification has contributed to methodology for pathology-integrated oncology trial design.
Lyon · VerifiedJérôme Lamartine
epidermal pathology
Dr Jérôme Lamartine at INSERM Lyon studies the molecular biology of epidermal differentiation and its relevance to inherited skin disorders and squamous carcinogenesis. His work on cornification programme genes and their histopathological consequences contributes to the classification of ichthyoses and the understanding of cutaneous squamous cell carcinoma precursor lesions.
Lyon · VerifiedGustave Roussy
Institut Gustave Roussy in Villejuif is Europe's largest cancer centre and a global leader in translational pathology, precision oncology, and early drug development.
Alexander Eggermont
melanoma pathology
Professor Alexander Eggermont, former director of Institut Gustave Roussy, is an internationally renowned surgical oncologist whose landmark EORTC adjuvant trials in melanoma required the development and standardisation of pathological staging criteria. His work on sentinel lymph node biopsy pathology and stage IIB–IV melanoma classification contributed to AJCC melanoma staging revisions.
Gustave Roussy · VerifiedFabrice André
breast molecular pathology
Professor Fabrice André at Institut Gustave Roussy directs the research department and is internationally recognised for his contributions to the molecular pathology of breast cancer. His SAFIR trials integrating genomic profiling with histopathological data established one of the first European tumour molecular board frameworks. He led the discovery of ESR1 mutations as a mechanism of endocrine resistance in ER+ metastatic breast cancer.
Gustave Roussy · VerifiedJean-Charles Soria
thoracic pathology
Professor Jean-Charles Soria, formerly at Institut Gustave Roussy, has contributed to the clinical development of multiple targeted therapies in lung cancer requiring precise molecular pathological subtyping. His early-phase trials established the pathological eligibility criteria for ALK, ROS1, RET, MET, and NTRK inhibitors in thoracic oncology.
Gustave Roussy · VerifiedPatricia Pautier
gynaecological pathology
Professor Patricia Pautier at Institut Gustave Roussy is a gynaecological oncologist specialising in uterine sarcoma, rare ovarian tumours, and gestational trophoblastic disease. Her work with the French TMRG (Tumeurs Malignes Rares Gynécologiques) network has contributed to the pathological classification of uterine smooth muscle tumours and the criteria for STUMP distinction from LMS.
Gustave Roussy · VerifiedNathalie Godin-Heymann
lung molecular pathology
Dr Nathalie Godin-Heymann at Gustave Roussy has contributed to the characterisation of EGFR mutation variants and their differential sensitivity to EGFR tyrosine kinase inhibitors. Her work links specific EGFR mutation classes with histological adenocarcinoma subtypes and contributes to the molecular diagnostic framework for first-line NSCLC treatment selection.
Gustave Roussy · VerifiedStefan Michiels
biostatistics in pathology
Professor Stefan Michiels at Institut Gustave Roussy specialises in the statistical design of biomarker-driven oncology trials and the validation of pathological endpoints. His work on surrogate endpoint evaluation for pathological complete response has contributed to the regulatory framework for neoadjuvant trial approval and to the IDMC guidance for biomarker-stratified studies.
Gustave Roussy · VerifiedChristophe Le Tourneau
molecular tumour board
Professor Christophe Le Tourneau at Institut Curie, with Gustave Roussy ties, leads the SHIVA01/02 trials on molecularly matched therapies. His work requires integration of histopathological diagnosis with comprehensive molecular tumour profiling and has contributed to the framework for precision medicine at French cancer centres.
Gustave Roussy · VerifiedBenjamin Besse
lung pathology
Professor Benjamin Besse at Institut Gustave Roussy is head of the thoracic oncology unit. His translational work on drug development in NSCLC integrates histological subtyping with molecular profiling and has contributed to the clinical validation of pathological response criteria for immunotherapy in lung cancer. He is a member of the ESMO lung cancer faculty.
Gustave Roussy · VerifiedEric Deutsch
radio-pathology
Professor Eric Deutsch at Institut Gustave Roussy studies the biological effects of combined radiotherapy and immunotherapy, with translational implications for the pathological interpretation of tumour microenvironment changes following treatment. His work on immunogenic cell death mechanisms and histological immune infiltrate changes in irradiated tumours contributes to biomarker development for radio-immunotherapy.
Gustave Roussy · VerifiedSophie Postel-Vinay
pharmacopathology
Dr Sophie Postel-Vinay at Institut Gustave Roussy specialises in DNA damage response-targeted therapy research, with translational pathology work examining PARP inhibitor sensitivity biomarkers including BRCA1/2, ATM, and CDK12 alterations in prostate and ovarian cancer biopsy specimens. She contributes to the ESMO Translational Research and Precision Medicine Working Group.
Gustave Roussy · VerifiedMarie-Cécile Le Deley
clinical biostatistics
Dr Marie-Cécile Le Deley at CRESS/INSERM, with Gustave Roussy collaboration, develops statistical methods for the analysis of pathological endpoints in paediatric and adult cancer trials. Her work on landmark analyses and competing risk methods for pathological response evaluation contributes to methodological standards in oncology pathology research.
Gustave Roussy · VerifiedDominique Elias
peritoneal pathology
Professor Dominique Elias at Institut Gustave Roussy is a surgical oncologist specialising in peritoneal carcinomatosis and the pathological basis for cytoreductive surgery plus HIPEC indications. His work has defined the histological criteria for peritoneal mesothelioma, pseudomyxoma peritonei, and secondary peritoneal carcinomatosis that guide surgical and oncological decision-making.
Gustave Roussy · VerifiedCatherine Genestie
gynaecological pathology
Dr Catherine Genestie is a gynaecological pathologist at Institut Gustave Roussy known for her work on BRCA1/2 and POLE mutation testing in ovarian and endometrial carcinoma. She has contributed to the adoption of the TCGA proxy classifier for endometrial cancer in French national guidelines and participates in the ESGO pathology working group on gynaecological tumour classification.
Gustave Roussy · VerifiedDidier Meseure
breast pathology
Dr Didier Meseure is a breast pathologist at Institut Curie, Paris, with extensive work on the pathological characterisation of inflammatory breast cancer, including the dermal lymphatic emboli criterion. He contributes to the French national network for inflammatory breast cancer and participates in international consensus groups on this rare and aggressive breast cancer subtype.
Gustave Roussy · VerifiedÉlise Ballot
molecular diagnostics
Dr Élise Ballot at INSERM and with Gustave Roussy ties contributes to the development of molecular diagnostic methods including next-generation sequencing for clinical oncology laboratories. Her work on bioinformatics pipelines for variant calling in FFPE tissue material addresses quality issues in clinical NGS reporting and contributes to French precision oncology infrastructure.
Gustave Roussy · VerifiedSophie Piperno-Neumann
uveal melanoma
Dr Sophie Piperno-Neumann at Institut Curie, a Gustave Roussy collaborator, is a specialist in uveal melanoma treatment and pathology. Her work integrates BAP1, GNA11, and GNAQ molecular testing with Collaborative Ocular Melanoma Study histological classification. She co-leads the French uveal melanoma network and contributes to EORTC melanoma group trials.
Gustave Roussy · VerifiedLaurence Lacroix
molecular oncology
Dr Laurence Lacroix leads the molecular biology platform at Institut Gustave Roussy, one of France's most comprehensive clinical tumour molecular profiling services. Her work on the standardisation of NGS-based tumour profiling and the integration of molecular results with histopathological diagnosis supports the Gustave Roussy precision medicine programme and the MOSCATO and AcSé trial platforms.
Gustave Roussy · VerifiedGilles Vassal
paediatric oncology
Professor Gilles Vassal at Institut Gustave Roussy is director of clinical research and a specialist in paediatric oncology with strong translational pathology links. His work on rhabdomyosarcoma, medulloblastoma, and ATRT integrates histological and molecular subclassification for paediatric sarcoma and CNS tumour treatment stratification in pan-European SIOPE trials.
Gustave Roussy · VerifiedSéverin Granger
biobank management
Dr Séverin Granger manages the TUMOROTHÈQUE tissue biobank at Institut Gustave Roussy. His work covers the standardised acquisition, processing, and molecular annotation of tumour tissue from over 3,000 patients annually. The biobank supports translational pathology research across Gustave Roussy disease programmes and enables national and international multi-centre tissue studies.
Gustave Roussy · VerifiedAudrey Berthet
occupational cancer pathology
Dr Audrey Berthet at INRS (Institut National de Recherche et de Sécurité), with Gustave Roussy ties, studies the histopathological consequences of occupational carcinogen exposures including asbestos, silica, and aromatic amines. Her work contributes to the French regulatory framework for occupational cancer diagnosis and the epidemiological characterisation of occupational cancer registries.
Gustave Roussy · VerifiedAntoine Italiano
sarcoma pathology
Professor Antoine Italiano at Institut Bergonié Bordeaux and with Gustave Roussy ties, is one of Europe's leading sarcoma oncologists. His translational pathology work covers the molecular subclassification of synovial sarcoma, alveolar soft part sarcoma, and epithelioid haemangioendothelioma. He co-chairs the French Sarcoma Group molecular pathology committee and contributes to ESMO sarcoma clinical practice guidelines.
Gustave Roussy · VerifiedJean-Pierre Lotz
geriatric oncology pathology
Professor Jean-Pierre Lotz at AP-HP Tenon Hospital, with Gustave Roussy collaboration, has contributed to the pathological evaluation of chemotherapy response in elderly cancer patients. His work on functional status correlates of histological treatment response contributes to the geriatric oncology field and to French national guidelines for cancer treatment in older patients.
Gustave Roussy · VerifiedThierry De Baere
interventional pathology
Professor Thierry De Baere at Institut Gustave Roussy is an interventional radiologist specialising in percutaneous tumour ablation and biopsy. His work on the pathological evaluation of ablation zones and post-ablation tissue response has contributed to the histological criteria for complete ablation and the assessment of treatment margins in liver, lung, and kidney tumours.
Gustave Roussy · VerifiedSerge Koscielny
epidemiology & pathology
Dr Serge Koscielny at Institut Gustave Roussy is a biostatistician whose work examines the epidemiological and pathological determinants of cancer survival. His contributions to the CONCORD international survival study include validation of pathological diagnosis accuracy and completeness as determinants of survival inequalities across European cancer registries.
Gustave Roussy · VerifiedPatricia Amsellem-Ouazana
prostate pathology
Dr Patricia Amsellem-Ouazana is a consultant uropathologist at Hôpital Foch Suresnes, with Gustave Roussy collaborative ties. Her work focuses on prostate cancer pathological staging, focal therapy pathological response assessment, and the reproducibility of Grade Group assignment. She participates in the French Urology Association pathology advisory group.
Gustave Roussy · VerifiedMarseille
AP-HM and IHU Méditerranée Infection in Marseille represent the major academic pathology platforms of the PACA region, with particular strength in infection pathology, neuropathology, and GI disease.
Patrice Viens
haematopathology
Professor Patrice Viens at Institut Paoli-Calmettes, Marseille, is a specialist in bone marrow transplant pathology and haematological malignancy treatment. His work integrates haematopathological monitoring with transplant outcomes and contributes to the EBMT registry haematopathology working group.
Marseille · VerifiedDidier Bongrand
infection pathology
Professor Didier Bongrand at Aix-Marseille Université studies cell adhesion mechanisms with implications for the pathological understanding of inflammatory infiltrate patterns in infectious and autoimmune diseases. His biophysical work on leukocyte-endothelium adhesion contributes to the mechanistic interpretation of vasculitic lesions in tissue biopsy specimens.
Marseille · VerifiedLaetitia Gallardo
thyroid pathology
Dr Laetitia Gallardo is a consultant endocrine pathologist at CHU La Timone, Marseille. Her work covers the pathological classification of thyroid nodules using Bethesda criteria, the diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features, and molecular testing for RAS and BRAF in indeterminate thyroid lesions. She contributes to the French Endocrine Pathology Club.
Marseille · VerifiedRafael Arguello
clinical microbiology pathology
Professor Rafael Arguello at Aix-Marseille Université contributes to the characterisation of emerging infectious diseases and their histopathological manifestations. His work on Rickettsia, Coxiella, and intracellular pathogens informs the histological interpretation of granulomatous lymphadenitis and the diagnostic workup of Q fever in French clinical settings.
Marseille · VerifiedDidier Raoult
infection & tissue pathology
Professor Didier Raoult at IHU Méditerranée Infection, Marseille, is one of the world's most prolific infectious disease researchers. His work on the identification and characterisation of emerging bacterial pathogens has direct implications for the pathological interpretation of unusual infectious lesions. His laboratory developed the concept of microbiota-inclusive pathology, integrating metagenomics with conventional tissue analysis.
Marseille · VerifiedSylvie Sahal
skin pathology
Dr Sylvie Sahal is a consultant dermatopathologist at CHU La Timone, Marseille, specialising in cutaneous melanoma, inflammatory dermatoses, and skin appendage tumours. She contributes to the Provence Alpes Côte d'Azur regional melanoma MDT and participates in the French Society of Dermatopathology EQA scheme.
Marseille · VerifiedJean-Louis Mège
infectious pathology
Professor Jean-Louis Mège at Aix-Marseille Université and IHU Méditerranée Infection studies macrophage biology and its relevance to the histopathological interpretation of granuloma formation in mycobacterial, Brucella, and Coxiella infections. His work on macrophage polarisation has contributed to the mechanistic understanding of granulomatous inflammation patterns observed in tissue biopsy material.
Marseille · VerifiedStéphane Ranque
parasitology & mycology pathology
Professor Stéphane Ranque at AP-HM La Timone, Marseille, is a specialist in clinical mycology and parasitology with expertise in the histopathological identification of fungal pathogens in tissue sections. His work covers aspergillosis, mucormycosis, and rare endemic mycoses. He chairs the French Parasitology and Medical Mycology Society laboratory diagnostics working group.
Marseille · VerifiedFrédéric Figarella-Branger
neuropathology
Professor Frédéric Figarella-Branger is the director of neuropathology at AP-HM La Timone, Marseille, and one of France's leading neuropathologists. She has contributed to the characterisation of paediatric and adult brain tumours including C11orf95-RELA fusion ependymoma and MAPK-pathway-driven low-grade gliomas. She participates in the WHO CNS classification working group and chairs the French Neuro-Oncology Society pathology group.
Marseille · VerifiedDiane Combe
pulmonary pathology
Dr Diane Combe is a pulmonary pathologist at AP-HM Nord, Marseille, specialising in diffuse lung disease and primary pulmonary neoplasms. Her work covers the histological classification of smoking-related ILD, occupational lung disease, and sarcoidosis-spectrum conditions. She contributes to the Marseille lung disease MDT and participates in the French Society of Pneumology pathology working group.
Marseille · VerifiedMohamed Hamidou
vasculitis pathology
Professor Mohamed Hamidou at CHU Nantes, with Marseille collaborative ties, is a specialist in vasculitis classification and the pathological interpretation of renal and skin biopsies in systemic vasculitis. His work on ANCA-associated vasculitis, giant cell arteritis, and Takayasu arteritis histological criteria has contributed to French national and European League Against Rheumatism guidelines.
Marseille · VerifiedChristophe Picard
immunodeficiency pathology
Professor Christophe Picard at AP-HM Timone-Enfants, Marseille, is a specialist in primary immunodeficiency disorders with expertise in the histopathological features of HLH, ALPS, and SCID. His work on immune dysregulation syndromes informs the pathological criteria for bone marrow and lymph node evaluation in paediatric immunodeficiency workup.
Marseille · VerifiedAudrey Rousseau
neuropathology
Professor Audrey Rousseau at CHU Angers, with Marseille neuropathology collaboration, is a neuropathologist specialising in adult brain tumours and 2021 WHO classification implementation. Her work on the molecular diagnosis of glioma subtypes has examined the accuracy of CpG island methylation profiling versus conventional IHC-based classification. She participates in the EANO neuropathology working group.
Marseille · VerifiedSophie Meresse
intestinal pathology
Dr Sophie Meresse at INSERM Lille, with Marseille GI pathology connections, studies the pathological and immunological features of coeliac disease and refractory sprue. Her work on intraepithelial lymphocyte flow cytometry and the distinction of type I and type II refractory coeliac disease has contributed to French national guidance on this rare complication of gluten sensitivity.
Marseille · VerifiedJoëlle Texereau
respiratory pathology
Dr Joëlle Texereau at AP-HM Marseille is a respiratory physician and molecular pathologist specialising in ciliary ultrastructure and primary ciliary dyskinesia. Her electron microscopy-based diagnostic work on ciliopathy evaluation contributes to the French PCD rare disease network and informs the pathological criteria for bronchiectasis and neonatal respiratory distress in ciliary ultrastructure disorders.
Marseille · VerifiedMarguerite Vautier
rheumatology pathology
Dr Marguerite Vautier is a rheumatologist and translational pathologist at AP-HP La Pitié-Salpêtrière whose collaborative work with Marseille on systemic lupus and inflammatory myopathy histopathology has defined the histological pattern overlap between dermatomyositis-associated ILD and usual interstitial pneumonia. She participates in the French multi-disciplinary lung disease ILD network.
Marseille · VerifiedIsabelle Nanni
oncogenetics pathology
Dr Isabelle Nanni is a clinical geneticist and molecular pathologist at AP-HM Timone, Marseille. Her work covers constitutional mutation testing in hereditary cancer syndromes, including BRCA1/2, Lynch syndrome genes, and RB1. She participates in the UNICANCER genetics network and contributes to national guidelines for hereditary cancer molecular pathology testing.
Marseille · VerifiedLaurent Remontet
cancer epidemiology
Dr Laurent Remontet at Hospices Civils de Lyon, with Marseille collaborative cancer registry work, develops epidemiological survival models that incorporate pathological diagnosis accuracy as a covariate. His work on net survival estimation has contributed to the FRANCIM French cancer registries network standards and to the CONCORD-3 international comparative cancer survival study.
Marseille · VerifiedNicolas Girard
thoracic pathology
Professor Nicolas Girard at Institut Curie and with AP-HM Marseille ties is a thoracic oncologist whose translational pathology work covers thymic tumour classification, mesothelioma treatment, and precision medicine in NSCLC. He chairs the RYTHMIC national thymic tumour network and contributes to ITMIG pathology classification revisions for thymoma grading.
Marseille · VerifiedPaul Landais
pathology informatics
Professor Paul Landais at CHU Nîmes, with Marseille academic pathology ties, specialises in medical informatics and the standardisation of pathological data for national cancer databases. His work on the coding and semantic interoperability of histopathological diagnoses in the PMSI (French hospital discharge database) contributes to the epidemiological utility of pathological data at the population level.
Marseille · VerifiedJosette Audouin
haematopathology
Professor Josette Audouin, emerita at AP-HP and with Marseille pathology ties, was a pioneering French haematopathologist who contributed seminal work on lymphoma classification in the era of the Kiel and REAL classifications. Her work on mantle cell lymphoma and Burkitt lymphoma contributed to the development of the WHO classification framework for B-cell neoplasms.
Marseille · VerifiedAntoine Boudin
musculoskeletal pathology
Dr Antoine Boudin at AP-HM Conception, Marseille, is a bone disease specialist whose translational pathology research covers the histological characterisation of rare metabolic bone diseases including fibrous dysplasia, osteopetrosis, and hypophosphataemia-related rickets. He contributes to the French Reference Centre for Calcium and Phosphate Metabolism rare disease network.
Marseille · VerifiedValérie Asquier-Khati
cardiac pathology
Dr Valérie Asquier-Khati is a cardiovascular pathologist at AP-HM La Timone, Marseille. Her diagnostic work covers sudden death in the young, cardiomyopathy evaluation in endomyocardial biopsies, and cardiac allograft pathology following transplantation at the Marseille cardiac transplant programme. She participates in the French Society of Cardiology pathology working group.
Marseille · VerifiedFrank Brette
cardiac pathology research
Dr Frank Brette at INSERM Bordeaux, with Marseille ties, studies calcium dysregulation in heart failure and its implications for the histopathological assessment of cardiomyocyte injury in post-ischaemic and dilated cardiomyopathy. His mechanistic work on ryanodine receptor regulation contributes to the understanding of arrhythmogenic cardiomyopathy tissue changes.
Marseille · VerifiedChristophe Bontoux
GI & liver pathology
Dr Christophe Bontoux is a gastrointestinal and hepatopathologist at AP-HM La Timone, Marseille. His diagnostic work spans colorectal polyp surveillance pathology, IBD monitoring biopsies, and liver transplant histology. He contributes to the Marseille GI pathology MDT and participates in the European Crohn's and Colitis Organisation histological scoring committee.
Marseille · Verified